IDLDX — IDL Diagnostics AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK93.99m
- SEK70.16m
- SEK57.44m
Annual income statement for IDL Diagnostics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.084 | 12 | 37 | 43 | 57.4 |
| Cost of Revenue | |||||
| Gross Profit | 0.063 | -5.04 | -2.1 | -2.1 | 11.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 24.1 | 62.6 | 96.3 | 103 | 101 |
| Operating Profit | -24.1 | -50.6 | -59.3 | -59.8 | -43.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -24.1 | -50.6 | -59.3 | -59.3 | -42.4 |
| Net Income After Taxes | -24.1 | -50.6 | -59.3 | -59.3 | -42.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -24.1 | -50 | -59 | -59.3 | -42.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24.1 | -50 | -59 | -59.3 | -42.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.327 | -0.32 | -0.09 | -0.086 | -0.012 |
| Dividends per Share |